Correlation Between Medical Developments and National Australia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medical Developments and National Australia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medical Developments and National Australia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medical Developments International and National Australia Bank, you can compare the effects of market volatilities on Medical Developments and National Australia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medical Developments with a short position of National Australia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medical Developments and National Australia.

Diversification Opportunities for Medical Developments and National Australia

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Medical and National is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Medical Developments Internati and National Australia Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National Australia Bank and Medical Developments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medical Developments International are associated (or correlated) with National Australia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National Australia Bank has no effect on the direction of Medical Developments i.e., Medical Developments and National Australia go up and down completely randomly.

Pair Corralation between Medical Developments and National Australia

Assuming the 90 days trading horizon Medical Developments International is expected to under-perform the National Australia. In addition to that, Medical Developments is 9.8 times more volatile than National Australia Bank. It trades about -0.03 of its total potential returns per unit of risk. National Australia Bank is currently generating about 0.08 per unit of volatility. If you would invest  9,822  in National Australia Bank on September 4, 2024 and sell it today you would earn a total of  778.00  from holding National Australia Bank or generate 7.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Medical Developments Internati  vs.  National Australia Bank

 Performance 
       Timeline  
Medical Developments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medical Developments International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Medical Developments is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
National Australia Bank 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in National Australia Bank are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, National Australia is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Medical Developments and National Australia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medical Developments and National Australia

The main advantage of trading using opposite Medical Developments and National Australia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medical Developments position performs unexpectedly, National Australia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National Australia will offset losses from the drop in National Australia's long position.
The idea behind Medical Developments International and National Australia Bank pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments